Dr. LoPiccolo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-5301Fax+1 617-632-5786
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 2017 - 2019
Albert Einstein College of MedicineClass of 2015
Certifications & Licensure
MA State Medical License 2019 - 2025
Publications & Presentations
PubMed
- 607 citationsTargeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerationsJaclyn LoPiccolo, Gideon M. Blumenthal, Wendy B. Bernstein, Phillip A. Dennis
Drug Resistance Updates. 2008-02-01 - 37 citationsRescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series.Jaclyn LoPiccolo, Megan D. Schollenberger, Sumia Dakhil, Samuel Rosner, Osama M.E. Ali
Journal for Immunotherapy of Cancer. 2019-07-08 - 94 citationsNelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy.Joell J. Gills, Jaclyn LoPiccolo, Phillip A. Dennis
Autophagy. 2008-01-01
Journal Articles
- Nodular Regenerative Hyperplasia Associated with Immune Checkpoint BlockadeEvan J Lipson, Michael I Brener, Jaclyn LoPiccolo, James P Hamilton, Hepatology
Press Mentions
Why Is Cancer Rising in Young Adults?January 21st, 2024- Attention Turns to Lung Cancer Cases in Those Who Never SmokedApril 18th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
